Related Experiment Video
Updated: Aug 15, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Identification of the jaundiced infant who is likely to recover without surgical intervention
Insights
This study introduces a Lipoprotein-X (LP-X) test with cholestyramine (CSM) to differentiate infant jaundice causes. A drop in LP-X suggests patent bile ducts, while a rise indicates biliary atresia, aiding diagnosis.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Jaundice
Background:
- Differentiating intrahepatic cholestasis from biliary atresia in infants with persistent jaundice is clinically challenging.
- Accurate diagnosis is crucial for timely surgical intervention and improved outcomes.
Purpose of the Study:
- To evaluate a diagnostic protocol using Lipoprotein-X (LP-X) levels before and after cholestyramine (CSM) administration.
- To determine the efficacy of this protocol in distinguishing between patent and atretic extrahepatic bile ducts.
Main Methods:
- A cohort of 32 infants with persistent jaundice underwent serial LP-X measurements.
- A short course of CSM was administered, followed by repeat LP-X testing.
- Surgical and histopathological findings were correlated with LP-X test results.
Main Results:
- A decrease in serum LP-X post-CSM indicated patent extrahepatic bile ducts.
- An increase in serum LP-X post-CSM suggested an atretic biliary system.
- The LP-X, CSM protocol could not differentiate subtypes of biliary atresia regarding surgical response.
Conclusions:
- The LP-X, CSM protocol effectively differentiates between patent and atretic extrahepatic bile ducts in infants with persistent jaundice.
- The presence of patent bile ducts is essential for successful hepatic portoenterostomy.
- None of the infants who underwent hepatic portoenterostomy had favorable anatomical findings for surgical success.
Abstract:
A series of 32 infants with persistant jaundice in whom an unequivocal differentiation between intrahepatic cholestasis and biliary atresia could not be made is reviewed. A protocol including Lipoprotein-X (LP-X) determinations before and after a short course of cholestyramine (CSM) was carried out in all. A fall in serum LP-X after CSM indicates the presence of patent extrahepatic bile ducts (even microscopic) which will function without benefit of hepatic portoenterostomy. A rise in LP-X levels after CSM means an atretic biliary system. The LP-X, CSM protocol was not able to differentiate between the anatomical variants of biliary atresia that may respond to hepatic portoenterostomy and those that will not. Patent bile ducts (even microscopic) in the porta hepatis and/or proximal hepatoduodenal ligament, which are in continuity with intrahepatic ducts, must be present if hepatic portoenterostomy is to be successful. None of our 12 infants undergoing hepatic portoenterostomy showed evidence of bile excretion after the procedure. Microscopic study of serial sections taken through the excised hepatoduodenal ligament tissues of these 12 infants revealed that none had anatomical findings conducive to the success of the operation.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Pyloric Obstruction

